The 42nd edition of the JPMorgan Health Conference took place last week, and one of the participants was Neola Medical. The Swedish medtech is currently preparing its lung monitoring system for a clinical study in the US. BioStock spoke to the company’s CEO Hanna Sjöström to get her impressions from the conference.

Read the article here: BioStock – Neolas rapid development recognised at JP Morgan